EUVIMEDEUVIMED entdecken
Crossref

Impact of PPAR agonists on seizure suppression to disease modification using status-epilepticus experimental model: Role of the PPAR in metabolic-inflammatory pathway

Surabhi Sinha, Sudhir Chandra Sarangi, Deeksha Sharma, Soumya Sucharita Pattnaik, Yajnaseni Dash, Aruna Nambirajan, Tapas Chandra Nag, Surender Singh, Manjari Tripathi

Brain Research · 2027-02 · 1896 · 150645

DOI: 10.1016/j.brainres.2026.150645 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Research, 2027-02. Verfasst von Surabhi Sinha und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), New Delhi, India. Die Arbeit nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This study explored the potential of peroxisome proliferator-activated receptor (α/γ) (PPAR modulators) for seizure control and the consequences of status epilepticus (SE) due to their anti-inflammatory and neuro-modulatory properties. METHOD: A lithium-pilocarpine-induced status epilepticus (SE) model in Wistar rats determined the optimal dose of PPAR modulators (fenofibrate, pemafibrate, and saroglitazar) for seizure suppression. Based on seizure parameters, an efficacy study examined PPAR modulators alone and in combination with ASMs (valproate and perampanel). Evaluations of disease-modifying effects included neurobehavioral tests, electron microscopy for neurodegeneration, immunohistochemistry (NeuN for neuronal viability and GFAP for astrocytosis), Western blotting for PPARα, HMGCS2, NLRP3, and mTOR, and ELISA for antioxidant capacity and neuroinflammatory biomarkers. RESULTS: The optimal doses of fenofibrate, pemafibrate, and saroglitazar were 200, 1.5, and 3 mg/kg, respectively. Compared with the SE-control group, drug-treated groups had higher latency (p

Schlagwörter

Stichwörter der Autor:innen

FenofibrateNeuro behaviorNeuronal damagePPAR agonistSeizureStatus epilepticus

Autor:innen und Institutionen

  • Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
  • Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), New Delhi, India. Electronic address: scsarangi@aiims.gov.in.
  • Department of Computer Science, KIET Group of Institutions, Ghaziabad, UP, India.
  • Department of Pathology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
  • Department of Anatomy, All India Institute of Medical Sciences (AIIMS), New Delhi, India.
  • Department of Neurology, All India Institute of Medical Sciences (AIIMS), New Delhi, India.

Zitieren

APA

Sinha, S., Sarangi, S. C., Sharma, D., Pattnaik, S. S., Dash, Y., Nambirajan, A., Nag, T. C., Singh, S., & Tripathi, M. (2027). Impact of PPAR agonists on seizure suppression to disease modification using status-epilepticus experimental model: Role of the PPAR in metabolic-inflammatory pathway. Brain Research, 1896, 150645. https://doi.org/10.1016/j.brainres.2026.150645

Vancouver

Sinha S, Sarangi SC, Sharma D, Pattnaik SS, Dash Y, Nambirajan A, et al. Impact of PPAR agonists on seizure suppression to disease modification using status-epilepticus experimental model: Role of the PPAR in metabolic-inflammatory pathway. Brain Research. 2027;1896:150645. doi:10.1016/j.brainres.2026.150645

BibTeX
@article{Sinha2027,
  author = {Sinha, Surabhi and Sarangi, Sudhir Chandra and Sharma, Deeksha and Pattnaik, Soumya Sucharita and Dash, Yajnaseni and Nambirajan, Aruna and Nag, Tapas Chandra and Singh, Surender and Tripathi, Manjari},
  title = {Impact of PPAR agonists on seizure suppression to disease modification using status-epilepticus experimental model: Role of the PPAR in metabolic-inflammatory pathway},
  journal = {Brain Research},
  year = {2027},
  volume = {1896},
  pages = {150645},
  doi = {10.1016/j.brainres.2026.150645}
}
Kostenlos starten →